Decreased Brain pH Correlated With Progression of Alzheimer Disease Neuropathology: A Systematic Review and Meta-Analyses of Postmortem Studies

Abstract Background Altered brain energy metabolism is implicated in Alzheimer disease (AD). Limited and conflicting studies on brain pH changes, indicative of metabolic alterations associated with neural activity, warrant a comprehensive investigation into their relevance in this neurodegenerative...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The international journal of neuropsychopharmacology 2024-10, Vol.27 (10), p.1
Hauptverfasser: Hagihara, Hideo, Miyakawa, Tsuyoshi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 10
container_start_page 1
container_title The international journal of neuropsychopharmacology
container_volume 27
creator Hagihara, Hideo
Miyakawa, Tsuyoshi
description Abstract Background Altered brain energy metabolism is implicated in Alzheimer disease (AD). Limited and conflicting studies on brain pH changes, indicative of metabolic alterations associated with neural activity, warrant a comprehensive investigation into their relevance in this neurodegenerative condition. Furthermore, the relationship between these pH changes and established AD neuropathological evaluations, such as Braak staging, remains unexplored. Methods We conducted quantitative meta-analyses on postmortem brain and cerebrospinal fluid pH in patients with AD and non-AD controls using publicly available demographic data. We collected raw pH data from studies in the NCBI GEO, PubMed, and Google Scholar databases. Results Our analysis of 20 datasets (723 patient samples and 524 control samples) using a random-effects model showed a significant decrease in brain and cerebrospinal fluid pH in patients compared with controls (Hedges’ g = −0.57, P 
doi_str_mv 10.1093/ijnp/pyae047
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11511658</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A817478697</galeid><oup_id>10.1093/ijnp/pyae047</oup_id><sourcerecordid>A817478697</sourcerecordid><originalsourceid>FETCH-LOGICAL-c333t-763f5c0f2873e70ea03bcb871765213836b5e1f4706c9081f248ae6ed46a01473</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhiMEoh9w44wscaAH0npix056QcsWKFKBioI4Wl5nsusqiYPtFIU_wV8mYZeKSgj5YGv8zKOx9SbJE6DHQEt2Yq-7_qQfNVIu7yX7wEWZ5gBw__cZUuC53EsOQrimNOM5Ew-TPVbyLGMC9pOfZ2g86oAVeeW17Uh_TpbOe2x0nGpfbdyQS-_WHkOwriOuJovmxwZti56c2TC3kg84eNfruHGNW4-nZEGuxhCx1dEa8glvLH4nuqvIe4w6XXS6GQOGWXXpQmydn1ByFYfKYniUPKh1E_Dxbj9Mvrx5_Xl5nl58fPtuubhIDWMsplKwOje0zgrJUFLUlK3MqpAgRZ4BK5hY5Qg1l1SYkhZQZ7zQKLDiQlPgkh0mL7fefli1WBnsoteN6r1ttR-V01bdvensRq3djQKYPlfkxWQ42hm8-zZgiKq1wWDT6A7dEBQDkGUpOYcJfbZF17pBZbvaTUoz42pRgOSyEOU80vE_qGlV2FrjOqztVL_T8GLbYLwLwWN9Oz5QNWdDzdlQu2xM-NO_n3wL_wnDBDzfAm7o_6_6BSLuxTA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3117997441</pqid></control><display><type>article</type><title>Decreased Brain pH Correlated With Progression of Alzheimer Disease Neuropathology: A Systematic Review and Meta-Analyses of Postmortem Studies</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford Journals Open Access Collection</source><source>PubMed Central</source><creator>Hagihara, Hideo ; Miyakawa, Tsuyoshi</creator><creatorcontrib>Hagihara, Hideo ; Miyakawa, Tsuyoshi</creatorcontrib><description>Abstract Background Altered brain energy metabolism is implicated in Alzheimer disease (AD). Limited and conflicting studies on brain pH changes, indicative of metabolic alterations associated with neural activity, warrant a comprehensive investigation into their relevance in this neurodegenerative condition. Furthermore, the relationship between these pH changes and established AD neuropathological evaluations, such as Braak staging, remains unexplored. Methods We conducted quantitative meta-analyses on postmortem brain and cerebrospinal fluid pH in patients with AD and non-AD controls using publicly available demographic data. We collected raw pH data from studies in the NCBI GEO, PubMed, and Google Scholar databases. Results Our analysis of 20 datasets (723 patient samples and 524 control samples) using a random-effects model showed a significant decrease in brain and cerebrospinal fluid pH in patients compared with controls (Hedges’ g = −0.57, P &lt; .0001). This decrease remained significant after considering postmortem interval, age at death, and sex. Notably, pH levels were negatively correlated with Braak stage, indicated by the random-effects model of correlation coefficients from 15 datasets (292 patient samples and 159 control samples) (adjusted r = −0.26, P &lt; .0001). Furthermore, brain pH enhanced the discriminative power of the APOEε4 allele, the most prevalent risk gene for AD, in distinguishing patients from controls in a meta-analysis of 4 combined datasets (95 patient samples and 87 control samples). Conclusions The significant decrease in brain pH in AD underlines its potential role in disease progression and diagnosis. This decrease, potentially reflecting neural hyperexcitation, could enhance our understanding of neurodegenerative pathology and aid in developing diagnostic strategies.</description><identifier>ISSN: 1461-1457</identifier><identifier>ISSN: 1469-5111</identifier><identifier>EISSN: 1469-5111</identifier><identifier>DOI: 10.1093/ijnp/pyae047</identifier><identifier>PMID: 39422361</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Alzheimer Disease - pathology ; Alzheimer's disease ; Autopsy ; Brain ; Brain - pathology ; Brain Chemistry ; Chemical properties ; Development and progression ; Disease Progression ; Health aspects ; Humans ; Hydrogen-Ion Concentration ; Medical research ; Medicine, Experimental ; Physiological aspects ; Regular</subject><ispartof>The international journal of neuropsychopharmacology, 2024-10, Vol.27 (10), p.1</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of CINP. 2024</rights><rights>The Author(s) 2024. Published by Oxford University Press on behalf of CINP.</rights><rights>COPYRIGHT 2024 Oxford University Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c333t-763f5c0f2873e70ea03bcb871765213836b5e1f4706c9081f248ae6ed46a01473</cites><orcidid>0000-0003-0137-8200 ; 0000-0001-9602-9518</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11511658/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11511658/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,1605,27928,27929,53795,53797</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39422361$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hagihara, Hideo</creatorcontrib><creatorcontrib>Miyakawa, Tsuyoshi</creatorcontrib><title>Decreased Brain pH Correlated With Progression of Alzheimer Disease Neuropathology: A Systematic Review and Meta-Analyses of Postmortem Studies</title><title>The international journal of neuropsychopharmacology</title><addtitle>Int J Neuropsychopharmacol</addtitle><description>Abstract Background Altered brain energy metabolism is implicated in Alzheimer disease (AD). Limited and conflicting studies on brain pH changes, indicative of metabolic alterations associated with neural activity, warrant a comprehensive investigation into their relevance in this neurodegenerative condition. Furthermore, the relationship between these pH changes and established AD neuropathological evaluations, such as Braak staging, remains unexplored. Methods We conducted quantitative meta-analyses on postmortem brain and cerebrospinal fluid pH in patients with AD and non-AD controls using publicly available demographic data. We collected raw pH data from studies in the NCBI GEO, PubMed, and Google Scholar databases. Results Our analysis of 20 datasets (723 patient samples and 524 control samples) using a random-effects model showed a significant decrease in brain and cerebrospinal fluid pH in patients compared with controls (Hedges’ g = −0.57, P &lt; .0001). This decrease remained significant after considering postmortem interval, age at death, and sex. Notably, pH levels were negatively correlated with Braak stage, indicated by the random-effects model of correlation coefficients from 15 datasets (292 patient samples and 159 control samples) (adjusted r = −0.26, P &lt; .0001). Furthermore, brain pH enhanced the discriminative power of the APOEε4 allele, the most prevalent risk gene for AD, in distinguishing patients from controls in a meta-analysis of 4 combined datasets (95 patient samples and 87 control samples). Conclusions The significant decrease in brain pH in AD underlines its potential role in disease progression and diagnosis. This decrease, potentially reflecting neural hyperexcitation, could enhance our understanding of neurodegenerative pathology and aid in developing diagnostic strategies.</description><subject>Alzheimer Disease - pathology</subject><subject>Alzheimer's disease</subject><subject>Autopsy</subject><subject>Brain</subject><subject>Brain - pathology</subject><subject>Brain Chemistry</subject><subject>Chemical properties</subject><subject>Development and progression</subject><subject>Disease Progression</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Physiological aspects</subject><subject>Regular</subject><issn>1461-1457</issn><issn>1469-5111</issn><issn>1469-5111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><sourceid>EIF</sourceid><recordid>eNp9kk1v1DAQhiMEoh9w44wscaAH0npix056QcsWKFKBioI4Wl5nsusqiYPtFIU_wV8mYZeKSgj5YGv8zKOx9SbJE6DHQEt2Yq-7_qQfNVIu7yX7wEWZ5gBw__cZUuC53EsOQrimNOM5Ew-TPVbyLGMC9pOfZ2g86oAVeeW17Uh_TpbOe2x0nGpfbdyQS-_WHkOwriOuJovmxwZti56c2TC3kg84eNfruHGNW4-nZEGuxhCx1dEa8glvLH4nuqvIe4w6XXS6GQOGWXXpQmydn1ByFYfKYniUPKh1E_Dxbj9Mvrx5_Xl5nl58fPtuubhIDWMsplKwOje0zgrJUFLUlK3MqpAgRZ4BK5hY5Qg1l1SYkhZQZ7zQKLDiQlPgkh0mL7fefli1WBnsoteN6r1ttR-V01bdvensRq3djQKYPlfkxWQ42hm8-zZgiKq1wWDT6A7dEBQDkGUpOYcJfbZF17pBZbvaTUoz42pRgOSyEOU80vE_qGlV2FrjOqztVL_T8GLbYLwLwWN9Oz5QNWdDzdlQu2xM-NO_n3wL_wnDBDzfAm7o_6_6BSLuxTA</recordid><startdate>20241001</startdate><enddate>20241001</enddate><creator>Hagihara, Hideo</creator><creator>Miyakawa, Tsuyoshi</creator><general>Oxford University Press</general><scope>TOX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0137-8200</orcidid><orcidid>https://orcid.org/0000-0001-9602-9518</orcidid></search><sort><creationdate>20241001</creationdate><title>Decreased Brain pH Correlated With Progression of Alzheimer Disease Neuropathology: A Systematic Review and Meta-Analyses of Postmortem Studies</title><author>Hagihara, Hideo ; Miyakawa, Tsuyoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c333t-763f5c0f2873e70ea03bcb871765213836b5e1f4706c9081f248ae6ed46a01473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Alzheimer Disease - pathology</topic><topic>Alzheimer's disease</topic><topic>Autopsy</topic><topic>Brain</topic><topic>Brain - pathology</topic><topic>Brain Chemistry</topic><topic>Chemical properties</topic><topic>Development and progression</topic><topic>Disease Progression</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Physiological aspects</topic><topic>Regular</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hagihara, Hideo</creatorcontrib><creatorcontrib>Miyakawa, Tsuyoshi</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The international journal of neuropsychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hagihara, Hideo</au><au>Miyakawa, Tsuyoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decreased Brain pH Correlated With Progression of Alzheimer Disease Neuropathology: A Systematic Review and Meta-Analyses of Postmortem Studies</atitle><jtitle>The international journal of neuropsychopharmacology</jtitle><addtitle>Int J Neuropsychopharmacol</addtitle><date>2024-10-01</date><risdate>2024</risdate><volume>27</volume><issue>10</issue><spage>1</spage><pages>1-</pages><issn>1461-1457</issn><issn>1469-5111</issn><eissn>1469-5111</eissn><abstract>Abstract Background Altered brain energy metabolism is implicated in Alzheimer disease (AD). Limited and conflicting studies on brain pH changes, indicative of metabolic alterations associated with neural activity, warrant a comprehensive investigation into their relevance in this neurodegenerative condition. Furthermore, the relationship between these pH changes and established AD neuropathological evaluations, such as Braak staging, remains unexplored. Methods We conducted quantitative meta-analyses on postmortem brain and cerebrospinal fluid pH in patients with AD and non-AD controls using publicly available demographic data. We collected raw pH data from studies in the NCBI GEO, PubMed, and Google Scholar databases. Results Our analysis of 20 datasets (723 patient samples and 524 control samples) using a random-effects model showed a significant decrease in brain and cerebrospinal fluid pH in patients compared with controls (Hedges’ g = −0.57, P &lt; .0001). This decrease remained significant after considering postmortem interval, age at death, and sex. Notably, pH levels were negatively correlated with Braak stage, indicated by the random-effects model of correlation coefficients from 15 datasets (292 patient samples and 159 control samples) (adjusted r = −0.26, P &lt; .0001). Furthermore, brain pH enhanced the discriminative power of the APOEε4 allele, the most prevalent risk gene for AD, in distinguishing patients from controls in a meta-analysis of 4 combined datasets (95 patient samples and 87 control samples). Conclusions The significant decrease in brain pH in AD underlines its potential role in disease progression and diagnosis. This decrease, potentially reflecting neural hyperexcitation, could enhance our understanding of neurodegenerative pathology and aid in developing diagnostic strategies.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>39422361</pmid><doi>10.1093/ijnp/pyae047</doi><orcidid>https://orcid.org/0000-0003-0137-8200</orcidid><orcidid>https://orcid.org/0000-0001-9602-9518</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1461-1457
ispartof The international journal of neuropsychopharmacology, 2024-10, Vol.27 (10), p.1
issn 1461-1457
1469-5111
1469-5111
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11511658
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford Journals Open Access Collection; PubMed Central
subjects Alzheimer Disease - pathology
Alzheimer's disease
Autopsy
Brain
Brain - pathology
Brain Chemistry
Chemical properties
Development and progression
Disease Progression
Health aspects
Humans
Hydrogen-Ion Concentration
Medical research
Medicine, Experimental
Physiological aspects
Regular
title Decreased Brain pH Correlated With Progression of Alzheimer Disease Neuropathology: A Systematic Review and Meta-Analyses of Postmortem Studies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T00%3A44%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decreased%20Brain%20pH%20Correlated%20With%20Progression%20of%20Alzheimer%20Disease%20Neuropathology:%20A%20Systematic%20Review%20and%20Meta-Analyses%20of%20Postmortem%20Studies&rft.jtitle=The%20international%20journal%20of%20neuropsychopharmacology&rft.au=Hagihara,%20Hideo&rft.date=2024-10-01&rft.volume=27&rft.issue=10&rft.spage=1&rft.pages=1-&rft.issn=1461-1457&rft.eissn=1469-5111&rft_id=info:doi/10.1093/ijnp/pyae047&rft_dat=%3Cgale_pubme%3EA817478697%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3117997441&rft_id=info:pmid/39422361&rft_galeid=A817478697&rft_oup_id=10.1093/ijnp/pyae047&rfr_iscdi=true